Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Exelon › Director received an award of 940 EXC shares Insider trades
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Dec 31, 2025
Reporting period Not applicable
Filed with the SEC Jan 3, 2026 Director Indirect holding Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
0001813403-26-000002
Filed / recorded Jan 3, 2026, 1:08 AM UTC
Added to OQRO Oct 2, 2026, 12:27 PM UTC
Data quality Verified: identifiers matched exactly
Reporting person Bryan K Segedi
Security Common stock- deferred stock units
Table Non-derivative (Table I)
Transaction date Dec 31, 2025
Acquired / disposed Acquired (A)
Ownership form Indirect — By Exelon Corp. Directors Deferred Stock Unit Plan
Footnotes from the filing Balance includes 68 additional shares acquired through automatic dividend reinvestment.
Around the same time Fund moves
61 tracked managers disclosed the same change for Q4 2025. From a 13F filed Jan 29, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
37 tracked managers disclosed the same change for Q4 2025. From a 13F filed Jan 22, 2026 covering holdings at Dec 31, 2025 — a quarter-end snapshot, not a live trade.
Insider filing
Traded Dec 31, 2025 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Oct 30, 2025 Congress · 1 person Members of Congress: 1 purchase, 1 sale Oct 31, 2025 Congress Disclosed sale of EXC — reported range $1,001 - $15,000 Nov 4, 2025 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Nov 18, 2025 Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit Plans Suspended trading under its employee plans Nov 24, 2025 Company filing · Form 8-K · Executive change Changed a top executive or board member “On November 26, 2025, Exelon Corporation (“Exelon”) announced that David Glockner, Executive Vice President, Compliance, Audit and Risk, will depart Exelon effective as of January 1, 2026.” Dec 4, 2025 Company filing · Form 8-K · Material agreement, New debt Signed an important agreement, and took on new debt or obligations (and 2 more items) What came next Feb 3, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On March 10, 2025, Exelon Corporation (“Exelon”) filed a Current Report on Form 8-K to report the appointment of David DeWalt to the Board of Directors (“Board”) effective as of that date.” Feb 12, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Feb 20, 2026 Company filing · Form 8-K · Material agreement, New debt Signed an important agreement, and took on new debt or obligations